Lan Shen
Impact in
-
- Cancer Genomics and Diagnostics
-
- Acute Myocardial Infarction Research
Papers in
-
- Inflammasome and immune disorders 2
- Surgery 5
- Bladder and Urothelial Cancer Treatments 2
- Co-authors
- Hsihui Chang (2 shared papers)Ke‐Hung Tsui (2 shared papers)Sheng Xu (1 shared paper)Tingting Shi (1 shared paper)Yaozu Xiang (1 shared paper)Feng Chen (1 shared paper)Kun Chen (1 shared paper)John Hwa (1 shared paper)
- Journals
- Coronary Artery Disease (2 papers)Advances in Therapy (2 papers)The International Journal of Biological Markers (2 papers)Clinical Cardiology (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lan Shen
38 papers receiving 488 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 70
- Cardiology and Cardiovascular Medicine 69
- Immunology 68
- Internal Medicine 9
- Nephrology 19
Countries citing papers authored by Lan Shen
This map shows the geographic impact of Lan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Shen more than expected).
Fields of papers citing papers by Lan Shen
This network shows the impact of papers produced by Lan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Shen. The network helps show where Lan Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction | 2022 | 80 |
| 2 | 2015 | 40 | |
| 3 | 2007 | 30 | |
| 4 | 2011 | 27 | |
| 5 | 2007 | 25 | |
| 6 | 2018 | 24 | |
| 7 | 2022 | 24 | |
| 8 | 2013 | 21 | |
| 9 | 2014 | 18 | |
| 10 | 2021 | 17 | |
| 11 | 2011 | 17 | |
| 12 | 2020 | 15 | |
| 13 | 2022 | 14 | |
| 14 | 2022 | 13 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 10 | |
| 17 | 2021 | 10 | |
| 18 | 2011 | 9 | |
| 19 | 2022 | 9 | |
| 20 | 2021 | 8 |
About Lan Shen
Lan Shen is a scholar working on Molecular Biology, Surgery, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 498 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (4 papers), Neuroscience and Neuropharmacology Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Epilepsy research and treatment (2 papers), Inflammasome and immune disorders (2 papers), Macrophage Migration Inhibitory Factor (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (70 citations), Cardiology and Cardiovascular Medicine (69 citations), Immunology (68 citations), Internal Medicine (9 citations) and Nephrology (19 citations). Lan Shen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hsihui Chang, Ke‐Hung Tsui, Sheng Xu, Tingting Shi, Yaozu Xiang, Feng Chen, Kun Chen, John Hwa, Yue Xu and Kai Jiang. Their work appears in journals such as Coronary Artery Disease, Advances in Therapy, The International Journal of Biological Markers, Clinical Cardiology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.